| Literature DB >> 32542214 |
Alan Rozanski1,2, Yoav Arnson3, Heidi Gransar2, Sean W Hayes2, John D Friedman2, Louise E J Thomson2, Damini Dey2, Daniel S Berman2.
Abstract
OBJECTIVE: To assess whether self-reported physical activity during daily life reduces the mortality risk associated with atherosclerotic burden, as measured by coronary artery calcium (CAC) scanning.Entities:
Keywords: ACM, all-cause mortality; CAC, coronary artery calcium; CAD, coronary artery disease; CT, computed tomography
Year: 2020 PMID: 32542214 PMCID: PMC7283959 DOI: 10.1016/j.mayocpiqo.2020.02.005
Source DB: PubMed Journal: Mayo Clin Proc Innov Qual Outcomes ISSN: 2542-4548
Study Population Characteristics
| Characteristic | All patients (N=2318) | Low physical activity (n=402) | Moderate physical activity (n=1365) | High physical activity (n=551) | Trend |
|---|---|---|---|---|---|
| Age (y), mean ± SD | 70.4±4.6 | 70.9±5.0 | 70.6±4.5 | 69.7±4.3 | .001 |
| Male sex (No. [%]) | 1285 (55.4) | 188 (46.8) | 746 (54.7) | 351 (63.7) | <.001 |
| Hypertension (No. [%]) | 1004 (43.3) | 205 (51.0) | 576 (42.2) | 223 (40.5) | <.002 |
| Dyslipidemia (No. [%]) | 1536 (66.3) | 265 (65.9) | 932 (68.3) | 339 (61.5) | .089 |
| Smoking (No. [%]) | 119 (5.1) | 31 (7.7) | 72 (5.3) | 16 (2.9) | <.001 |
| Diabetes (No. [%]) | 179 (7.7) | 47 (11.7) | 101 (7.4) | 31 (5.6) | <.001 |
| Family history of CAD (No. [%]) | 650 (28.0) | 112 (27.9) | 414 (30.3) | 124 (22.5) | .031 |
| BMI (mean ± SD) | 25.8±4.2 | 27.2±4.8 | 25.8±4.2 | 24.7±3.6 | <.001 |
| <25 (No. [%]) | 1076 (46.4) | 152 (37.8) | 609 (44.6) | 315 (57.2) | <.001 |
| 25-29 (No. [%]) | 927 (40.0) | 147 (36.6) | 586 (42.9) | 194 (35.2) | .403 |
| ≥30 (No. [%]) | 315 (13.6) | 103 (25.6) | 170 (12.5) | 42 (7.6) | <.001 |
| Chest pain symptoms (No. [%]) | |||||
| Asymptomatic | 1842 (79.5) | 301 (74.9) | 1074 (78.7) | 467 (84.8) | <.001 |
| Nonanginal pain | 208 (9.0) | 40 (10.0) | 132 (9.7) | 36 (6.5) | .048 |
| Atypical angina | 136 (5.9) | 32 (8.0) | 82 (6.0) | 22 (4.0) | .009 |
| Typical angina | 41 (1.8) | 8 (2.0) | 26 (1.9) | 7 (1.3) | .369 |
| Dyspnea only | 91 (3.9) | 21 (5.2) | 51 (3.7) | 19 (3.5) | .188 |
| Medications (No. [%]) | |||||
| β-blockers | 286 (12.3) | 47 (11.7) | 180 (13.2) | 59 (10.7) | .527 |
| Calcium blockers | 212 (9.2) | 46 (11.4) | 117 (8.6) | 49 (8.9) | .230 |
| ACE inhibitors | 324 (14.0) | 66 (16.4) | 190 (13.9) | 68 (12.3) | .077 |
| Lipid-lowering medications | 857 (37.0) | 160 (39.8) | 507 (37.1) | 190 (34.5) | .091 |
| Aspirin | 1135 (49.0) | 178 (44.3) | 689 (50.5) | 268 (48.6) | .267 |
| CAC scores | |||||
| Mean ± SD | 392.6±776.9 | 416.7±789.5 | 391.8±793.6 | 376.9±724.9 | |
| Median (interquartile range) | 106.5 (7.5-430.2) | 128.9 (23.3-501.3) | 101.6 (4.8-416.0) | 98.8 (8.7-404.7) | .196 |
| Category (No. [%]) | |||||
| 0 | 451 (19.5) | 63 (15.7) | 287 (21.0) | 101 (18.3) | .459 |
| 1-99 | 683 (29.5) | 116 (28.9) | 392 (28.7) | 175 (31.8) | .281 |
| 100-399 | 573 (24.7) | 108 (26.9) | 329 (24.1) | 136 (24.7) | .505 |
| 400-999 | 361 (15.6) | 69 (17.2) | 208 (15.2) | 84 (15.3 | .461 |
| ≥1000 | 250 (10.8) | 46 (11.4) | 149 (10.9) | 55 (10.0) | .458 |
| Percentile score (mean ± SD) | 48.0±33.0 | 53.4±32.2 | 46.8±33.5 | 47.1±32.1 | .007 |
| Mortality incidence (No. [%]) | 533 (23.0) | 119 (29.6) | 321 (23.5) | 93 (16.9) | <.001 |
| Annual mortality (% [95% CI]) | 2.3 (2.1-2.5) | 2.9 (2.4-3.4) | 2.3 (2.1-2.6) | 1.7 (1.4-2.1) | <.001 |
ACE = angiotensin-converting enzyme; BMI = body mass index (calculated as weight in kilograms divided by height in meters squared); CAC = coronary artery calcium; CAD = coronary artery disease.
Figure 1Kaplan-Meier survival curves for all-cause mortality (ACM) among patients divided according to level of reported physical activity in 3 coronary artery calcium (CAC) groups (scores of 0-99, 100-399, and ≥400).
Hazard Ratios for All-cause mortality in the Patient Cohortab
| Group | Patients (No.) | Hazard ratios | |||
|---|---|---|---|---|---|
| Unadjusted | Risk adjusted | ||||
| CAC score | |||||
| 0-99 | 1134 | 1 (Referent) | 1 (Referent) | ||
| 100-399 | 573 | 1.40 (1.12-1.75) | .003 | 1.21 (0.95-1.55) | .12 |
| ≥400 | 611 | 2.07 (1.70-2.52) | <.001 | 1.59 (1.26-2.01) | <.001 |
| Physical activity level | |||||
| High | 551 | 1 (Referent) | 1 (Referent) | ||
| Moderate | 1365 | 1.39 (1.10-1.74) | .006 | 1.26 (0.98-1.63) | .08 |
| Low | 402 | 1.68 (1.28-2.20) | <.001 | 1.60 (1.18-2.17) | .003 |
| CAC score/physical activity level | |||||
| 0-99/high | 276 | 1 (Referent) | 1 (Referent) | ||
| 0-99/moderate | 679 | 1.19 (0.82-1.73) | .36 | 1.01 (0.67-1.52) | .96 |
| 0-99/low | 179 | 1.14 (0.70-1.85) | .59 | 0.97 (0.57-1.64) | .90 |
| 100-399/high | 136 | 1 (Referent) | 1 (Referent) | ||
| 100-399/moderate | 329 | 1.07 (0.69-1.66) | .77 | 1.15 (0.71-1.87) | .58 |
| 100-399/low | 108 | 1.37 (0.83-2.29) | .22 | 2.07 (1.16-3.69) | .01 |
| ≥400/high | 139 | 1 (Referent) | 1 (Referent) | ||
| ≥400/moderate | 357 | 1.91 (1.28-2.83) | .001 | 1.68 (1.06-2.66) | .03 |
| ≥400/low | 115 | 2.63 (1.69-4.10) | <.001 | 2.35 (1.39-3.97) | .001 |
CAC = coronary artery calcium.
A formal test for interaction showed that the Wald P value interaction between CAC score and physical activity level was significant (P=.013 unadjusted and P=.009 risk adjusted).
Hazard ratios adjusted for age, male sex, hypertension, dyslipidemia, smoking, diabetes, and family history of premature coronary artery disease, lipid-lowering medication use, and blood pressure medication use.
Figure 2All-cause mortality (ACM) rates (per 1000 person-years) according to increasing coronary artery calcium (CAC) score and level of reported physical activity.
Multivariable Predictors of All-cause Mortality
| Variable | χ2 | MVA HR (95% CI) | |
|---|---|---|---|
| Age, per 5 years | 120.38 | <.001 | 1.70 (1.55-1.86) |
| CAC score | 18.63 | <.001 | |
| 0 | 1 (Referent) | ||
| 1-99 | 0.95 (0.70-1.30) | ||
| 100-399 | 1.21 (0.89-1.64) | ||
| ≥400 | 1.56 (1.16-2.11) | ||
| Physical activity level | 9.04 | .01 | |
| High | 1 (Referent) | ||
| Moderate | 1.27 (1.00-1.61) | ||
| Low | 1.55 (1.16-2.07) | ||
| Diabetes | 4.50 | .03 | 1.39 (1.04-1.86) |
| Chest pain symptoms | 4.01 | .41 | |
| Asymptomatic | 1 (Referent) | ||
| Nonanginal chest pain | 1.30 (0.96-1.75) | ||
| Atypical angina | 1.13 (0.80-1.60) | ||
| Typical angina | 1.32 (0.76-2.30) | ||
| Dyspnea only | 0.80 (0.25-2.50) | ||
| Smoking | 3.81 | .05 | 1.39 (1.01-1.92) |
| Hypertension | 2.42 | .12 | 1.15 (0.96-1.38) |
| Body mass index, per 5 kg/m2 | 1.97 | .16 | 0.92 (0.82-1.03) |
| Dyslipidemia | 1.30 | .25 | 0.90 (0.75-1.08) |
| Male sex | 0.67 | .41 | 1.09 (0.89-1.33) |
| Family history of premature CAD | 0.06 | .81 | 0.97 (0.79-1.20) |
CAC = coronary artery calcium; CAD = coronary artery disease; HR = hazard ratio; MVA = multivariate analysis.